MEF2C and Alzheimer disease: Compared with control tissues, expression levels of NPTX2, RTN1, UBE2N and MEF2C were significantly decreased, while expression levels of IQGAP1 and TGFBR3 were increased in all the four different brain regions of patients with AD (Figure 3).